Mosaic Shorts Hold Ground After Q3 Miss

MOS reported its Q3 results on November 4, and the numbers landed into an already-weakened stock: shares are down 12.6% over the past month to $18.42, and short sellers had spent October positioning for exactly this kind of disappointment.

Short interest in Mosaic has climbed steadily through October, reaching 11.5% of the free float as of November 3. That is the highest level in at least a year, and the pace of the build is striking: positions are up 5.4% on the week and 20.8% on the month. The borrow market, however, is not signalling any stress. Availability remains at 430%, meaning roughly four shares are available to lend for every one currently borrowed, and the cost to borrow is just 0.54%. New short positions can still be opened cheaply and freely, which means the accumulation reflects deliberate directional conviction rather than any mechanical squeeze dynamic. The ORTEX short score has drifted up to 57.6, its highest reading in the recent data, and ranks in the 6th percentile of all stocks on a short-score basis, confirming the bearish lean is systematic and building.

The Street has moved in one direction for weeks. UBS cut its target to $19 from $23 on October 27, and that was part of a broader wave: Barclays, CIBC, Mizuho and RBC all trimmed targets in October, with RBC also downgrading to Sector Perform from Outperform. Freedom Broker upgraded its rating to Hold from Sell this week but kept its target at $17, below the current price. With no buy ratings in the consensus and 11 holds, the analyst community is cautious but not panicked. The stock trades on a price-to-book of roughly 0.5 and an EV/EBITDA of 5.6x, both compressed multiples that reflect earnings uncertainty rather than a growth premium. The EPS surprise factor score sits at the 1st percentile, meaning the company has not been in the habit of beating expectations.

The operational picture supplies the rationale. The bear case centres on production reliability problems at the Riverview and Bartow phosphate facilities, weak Brazilian fertilizer demand and elevated sulfur costs. ORTEX Alt Data provides one real-economy data point worth noting: MSHA filings show that employee hours worked at Mosaic's mines hit the smallest Q2 reading on record, back to 2010, at 506,613 hours in the April 2026 period. Average employee headcount also reached a record low for a Q2 at 856. Those are factual observations about operations, not a leading indicator of financial performance, since neither dataset has been measured to lead the company's reported figures. But they are consistent with the production difficulties the bears have been citing.

One institutional holder worth watching is Lingotto Investment Management, which appears in the top-holder list with 13.3 million shares, a position that is entirely new in the September 30 data. State Street also added meaningfully, taking on roughly 4.3 million shares in the quarter. BlackRock, meanwhile, has been a seller: its 13G filing from April 2025 showed a reduction from 9.0% to 6.7% of shares, and its latest reported holding is 24.8 million shares, still the largest single institutional block. No activist 13D has been filed against the company.

ORTEX puts the probability of Mosaic being removed from the S&P 500 at 73% at the December 2026 Quarterly Review, with the stock's current market cap of $5.9 billion sitting well below the $11.3 billion that marks the index exit line. If that deletion is confirmed, index trackers would need to sell roughly $1.2 billion of stock, equivalent to about 7.1 days of normal trading volume, on the December 18 trade date. ORTEX simultaneously puts the probability of an addition to the S&P SmallCap 600 at 73%, which would bring an estimated $590 million of buying. Among 21 past S&P 500 deletions of this type, the median move from announcement to effective date was minus 1.8%, with 57% moving in that expected direction. The practical question for the next six weeks is whether the Q3 results change the market-cap trajectory enough to shift those probabilities, with the rank date for the December review set for December 1.